INPPL1 and Dravet syndrome: Strong immunoreactivity of SHIP2 was observed in a DS/AD case exhibiting severe AD lesions (Fig. 4b), CAA (Fig. 4c) and a combined case of diffuse Lewy body disease with AD (AD/DLBD) (Fig. 4d).